ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » North Carolina » Geriatric Medicine

Top Geriatric Medicine Prescribers in North Carolina

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
EDDIE POWELL M.D.

Geriatric Medicine

48,447

$2.78M

1007
480 are 65+

7%
patients receiving schedule two controlled substances

Avg: 12%

16%
patients receiving schedule three controlled substances

Avg: 9%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $58

ARTHUR GREEN MD

Geriatric Medicine

43,974

$2.54M

1158
1050 are 65+

20%
patients receiving schedule two controlled substances

Avg: 12%

13%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$58
Average prescription price

Avg: $58

BLAIR HOLL MD

Geriatric Medicine

34,136

$1.99M

574
466 are 65+

25%
patients receiving schedule two controlled substances

Avg: 12%

28%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$58
Average prescription price

Avg: $58

MAHESH DUGGAL MD

Geriatric Medicine

28,985

$1.59M

647
577 are 65+

17%
patients receiving schedule two controlled substances

Avg: 12%

35%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $58

MICHAEL ROBSON MD

Geriatric Medicine

26,027

$1.58M

722
604 are 65+

21%
patients receiving schedule two controlled substances

Avg: 12%

14%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $58

ALBERT FORD M.D.

Geriatric Medicine

25,619

$1.46M

720
483 are 65+

12%
patients receiving schedule two controlled substances

Avg: 12%

12%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $58

HONG YU M.D.

Geriatric Medicine

23,430

$1.58M

549
461 are 65+

22%
patients receiving schedule two controlled substances

Avg: 12%

5%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$67
Average prescription price

Avg: $58

HAL STONEKING MD

Geriatric Medicine

23,328

$1.63M

893
846 are 65+

4%
patients receiving schedule two controlled substances

Avg: 12%

7%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$70
Average prescription price

Avg: $58

MARIA-DORINA SEVILLA M.D.

Geriatric Medicine

20,208

$1.23M

431
383 are 65+

15%
patients receiving schedule two controlled substances

Avg: 12%

14%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $58

JONG KIM MD

Geriatric Medicine

18,362

$1.4M

481
299 are 65+

24%
patients receiving schedule two controlled substances

Avg: 12%

33%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 25%

$76
Average prescription price

Avg: $58

DONALD CULVER MD

Geriatric Medicine

16,786

$850K

380
347 are 65+

24%
patients receiving schedule two controlled substances

Avg: 12%

25%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $58

JOSETTE MARIA MD

Geriatric Medicine

16,256

$1.08M

538
265 are 65+

36%
patients receiving schedule two controlled substances

Avg: 12%

8%
patients receiving schedule three controlled substances

Avg: 9%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$66
Average prescription price

Avg: $58

MEENA SEKARAN MD

Geriatric Medicine

16,173

$671K

599
478 are 65+

0%
patients receiving schedule two controlled substances

Avg: 12%

7%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$42
Average prescription price

Avg: $58

JOHN WHITLOCK M.D.

Geriatric Medicine

15,448

$840K

461
402 are 65+

7%
patients receiving schedule two controlled substances

Avg: 12%

17%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $58

JOE FRAZER MD

Geriatric Medicine

15,181

$683K

284
257 are 65+

47%
patients receiving schedule two controlled substances

Avg: 12%

12%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$45
Average prescription price

Avg: $58

TAMAS SOOS M.D.

Geriatric Medicine

15,167

$934K

482
386 are 65+

16%
patients receiving schedule two controlled substances

Avg: 12%

10%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$62
Average prescription price

Avg: $58

PEARLY GRAHAM-HOSKINS MD

Geriatric Medicine

15,114

$773K

442
344 are 65+

6%
patients receiving schedule two controlled substances

Avg: 12%

25%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $58

ABAYOMI OSUNKOYA M.D.

Geriatric Medicine

15,014

$1.13M

482
331 are 65+

16%
patients receiving schedule two controlled substances

Avg: 12%

16%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 25%

$75
Average prescription price

Avg: $58

IFTEQUAR AHMED M.D.

Geriatric Medicine

14,577

$938K

484
407 are 65+

0%
patients receiving schedule two controlled substances

Avg: 12%

6%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$64
Average prescription price

Avg: $58

MAURICE BIENENFELD M.D.

Geriatric Medicine

12,971

$767K

637
583 are 65+

3%
patients receiving schedule two controlled substances

Avg: 12%

7%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $58

DEANNA MANGIERI D.O.

Geriatric Medicine

11,129

$588K

567
450 are 65+

8%
patients receiving schedule two controlled substances

Avg: 12%

18%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $58

KAVITA PERSAUD M.D.

Geriatric Medicine

10,953

$707K

295
275 are 65+

21%
patients receiving schedule two controlled substances

Avg: 12%

14%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $58

GAYANI DASANAYAKA MD

Geriatric Medicine

10,904

$713K

244
205 are 65+

16%
patients receiving schedule two controlled substances

Avg: 12%

12%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $58

ABDOLHAKIM NIAZI-SAI MD FACP FRCP C

Geriatric Medicine

10,417

$426K

211
166 are 65+

22%
patients receiving schedule two controlled substances

Avg: 12%

5%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$41
Average prescription price

Avg: $58

YEDDU RAJU MD

Geriatric Medicine

10,249

$541K

301
130 are 65+

7%
patients receiving schedule two controlled substances

Avg: 12%

10%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $58

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank